VIA
GWPH

Vident Investment Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Vident Investment Advisory’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,988
Closed -$334K – 504
2016
Q4 		$334K Buy
+2,988
New +$360K 0.04% 364

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vident Investment Advisory's GWPH Position: Q1 2017 in Review

Vident Investment Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2017, closing a stake of 2,988 shares — an estimated $334K sold.

Vident Investment Advisory first reported a position in GWPH in Q4 2016 and held it in 1 quarter. The position peaked at $334K in Q4 2016. 179 funds tracked by Wall St. Rank hold GWPH as of Q1 2017.

  • Vident Investment Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2017 after selling out during the quarter.
  • Vident Investment Advisory sold 2,988 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2017, an estimated $334K.
  • Vident Investment Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 1 quarter.
  • Vident Investment Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $334K in Q4 2016.
  • 179 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2017.

Based on Vident Investment Advisory's 13F filing for Q1 2017, filed 10 May 2017.